David P. Perry, President and CEO at Anacor Pharmaceuticals, Inc. (ANAC), sold 65,000 shares at $16.30 ($1.1M) on 2014-01-08, disclosed to the SEC on 2014-01-09.
Scheduled sale ($1.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.30 | 7,500 | $122K | 11.5% |
| 2 | $16.30 | 50,000 | $815K | 76.8% |
| 3 | $16.49 | 7,500 | $124K | 11.7% |
| Total | $16.32 avg | 65,000 | $1.1M | 100% |
| Filing → |
| ANAC | SELL | 2014-02-05 | $255K | — | Filing → |
| ANAC | SELL | 2013-12-09 | $655K | — | Filing → |